Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov;58(6):492.
doi: 10.4103/0019-5154.119973.

Bullous systemic lupus erythematosus

Affiliations

Bullous systemic lupus erythematosus

Chander Grover et al. Indian J Dermatol. 2013 Nov.

Abstract

Bullous Systemic Lupus Erythematosus (BSLE) is a rare manifestation of Systemic Lupus Erythematosus (SLE), characterized histologically by subepidermal bullae with predominantly neutrophilic infiltrate and immunoglobulin (IgG, IgA, IgM) and C3 deposition at the basement membrane zone. Often associated is a heterogeneous profile of autoimmunity to components of type VII collagen. It needs to be differentiated from other subepidermal bullous diseases in view of potentially associated systemic manifestations of SLE. We report a 39-year-old lady who presented with an extensive vesicobullous eruption on face, neck, trunk, and mucosa. She was also found to have photosensitivity, significant anemia, and high antibody titers confirming SLE. Routine histopathology and immunoflorescence studies suggested BSLE and she responded favorably to dapsone. The importance of clinical and histopathological findings in confirming a diagnosis of BSLE along with the very encouraging response to dapsone therapy is highlighted.

Keywords: Dapsone; immunobullous diseases; type VII collagen.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Figures

Figure 1
Figure 1
Presence of tense vesicles (marked with an arrow) filled with cleat fluid along with superficial erosions with polycyclic margins. Lesions are present on covered as well as exposed areas
Figure 2
Figure 2
Biopsy taken from vesicular lesion revealed a subepidermal split, containing numerous red blood cells. A marked neutrophilic infiltrate is seen in the papillary dermis (H and E, ×250). Inset shows a positive lupus band (IgG) at the basement membrane zone)
Figure 3
Figure 3
Marked improvement seen 1 week after starting dapsone therapy

Similar articles

Cited by

References

    1. Yung A, Oakley A. Bullous systemic lupus erythematosus. Australas J Dermatol. 2000;41:234–7. - PubMed
    1. Chan LS, Lapiere JC, Chen M, Traczyk T, Mancini AJ, Paller AS, et al. Bullous systemic lupus erythematosus with antibodies recognizing multiple basement membrane components, bullous pemphigoid antigen1, lamini-5, laminin-6, and type VII collagen. Arch Dermatol. 1999;135:569–73. - PubMed
    1. Gammon WR, Briggaman RA. Bullous eruption of systemic lupus erythematosus. In: Wojnarowska F, Briggaman RA, editors. Management of Blistering Diseases. London: Chapman and Hall Ltd; 1990. pp. 263–75.
    1. Vassileve S. Bullous systemic lupus erythematosus. Clin Dermatol. 2004;22:129–38. - PubMed
    1. Gammon WR, Briggaman RA. Bullous SLE: A phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol. 1993;100:28S–34. - PubMed

LinkOut - more resources